Motif ID: Gtf2i_Gtf2f1
Z-value: 2.157
Transcription factors associated with Gtf2i_Gtf2f1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Gtf2f1 | ENSMUSG00000002658.9 | Gtf2f1 |
| Gtf2i | ENSMUSG00000060261.9 | Gtf2i |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Gtf2i | mm10_v2_chr5_-_134314637_134314676 | 0.33 | 1.3e-02 | Click! |
| Gtf2f1 | mm10_v2_chr17_-_57011271_57011326 | -0.24 | 7.5e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.6 | 37.9 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 11.2 | 33.5 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 8.5 | 34.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 6.3 | 38.0 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 6.0 | 36.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 4.6 | 18.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 4.2 | 46.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 4.0 | 19.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 3.9 | 11.7 | GO:0002159 | desmosome assembly(GO:0002159) |
| 3.7 | 14.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 3.6 | 36.5 | GO:0046959 | habituation(GO:0046959) |
| 3.6 | 14.4 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.5 | 7.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 3.5 | 10.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 3.4 | 24.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 3.2 | 16.1 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 3.2 | 38.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 3.2 | 9.5 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
| 3.2 | 15.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 3.1 | 9.3 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 3.1 | 12.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 3.0 | 9.1 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 3.0 | 12.1 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 3.0 | 8.9 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.9 | 11.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 2.9 | 5.8 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
| 2.9 | 8.6 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 2.9 | 8.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.8 | 8.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 2.8 | 2.8 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 2.8 | 11.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 2.8 | 11.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 2.8 | 13.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 2.7 | 8.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 2.7 | 8.2 | GO:0038095 | positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 2.7 | 42.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 2.6 | 13.0 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 2.6 | 2.6 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 2.5 | 15.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 2.5 | 7.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.4 | 9.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 2.4 | 21.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 2.4 | 11.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 2.3 | 11.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 2.3 | 11.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 2.3 | 27.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 2.3 | 9.2 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 2.2 | 6.6 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 2.1 | 6.4 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 2.1 | 10.6 | GO:0042117 | monocyte activation(GO:0042117) |
| 2.1 | 14.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 2.1 | 8.2 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 2.0 | 4.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 2.0 | 7.9 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 2.0 | 5.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.9 | 5.7 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.9 | 1.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 1.9 | 9.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.8 | 1.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) regulation of calcium:sodium antiporter activity(GO:1903279) |
| 1.8 | 9.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.8 | 5.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.8 | 7.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.8 | 3.5 | GO:1905165 | regulation of lysosomal protein catabolic process(GO:1905165) |
| 1.7 | 1.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 1.7 | 8.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.7 | 8.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.7 | 6.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.6 | 26.0 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.6 | 4.9 | GO:0060023 | soft palate development(GO:0060023) |
| 1.6 | 1.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 1.6 | 6.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 1.6 | 23.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 1.6 | 4.7 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 1.6 | 3.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.6 | 7.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.5 | 4.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 1.5 | 4.6 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.5 | 9.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.5 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 1.5 | 10.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.5 | 4.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.5 | 6.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 1.5 | 3.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.5 | 4.4 | GO:0030070 | insulin processing(GO:0030070) |
| 1.5 | 13.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 1.4 | 4.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.4 | 14.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 1.4 | 4.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.4 | 6.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 1.4 | 8.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 1.4 | 8.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 1.3 | 8.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 1.3 | 5.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 1.3 | 8.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.3 | 8.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.3 | 8.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 1.3 | 5.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.3 | 1.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 1.3 | 2.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.3 | 6.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.3 | 3.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.3 | 17.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 1.3 | 6.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 1.3 | 3.8 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.3 | 3.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.2 | 2.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.2 | 8.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 1.2 | 17.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 1.2 | 4.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.2 | 9.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 1.2 | 1.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
| 1.2 | 19.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.2 | 2.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.2 | 5.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 1.2 | 2.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 1.2 | 1.2 | GO:1902514 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 1.2 | 7.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.2 | 3.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 1.2 | 3.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 1.1 | 7.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.1 | 5.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 1.1 | 4.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.1 | 5.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 1.1 | 1.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.0 | 17.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.0 | 4.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.0 | 9.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.0 | 4.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.0 | 4.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.0 | 7.1 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.0 | 3.0 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.0 | 11.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 1.0 | 8.9 | GO:0098907 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 1.0 | 10.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 1.0 | 4.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.0 | 4.8 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.0 | 1.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 1.0 | 1.9 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.0 | 4.8 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.9 | 2.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.9 | 2.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.9 | 5.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.9 | 2.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.9 | 3.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.9 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.9 | 1.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.9 | 2.7 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.9 | 3.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 | 8.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.9 | 5.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.9 | 6.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.9 | 2.7 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.9 | 4.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.9 | 4.4 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 0.9 | 1.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.9 | 4.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.9 | 2.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.9 | 3.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.9 | 6.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.9 | 1.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.8 | 0.8 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.8 | 6.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.8 | 21.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.8 | 5.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.8 | 7.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.8 | 2.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.8 | 1.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.8 | 7.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.8 | 3.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.8 | 1.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.8 | 2.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.8 | 2.3 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
| 0.8 | 5.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.8 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.8 | 3.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.8 | 3.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.8 | 13.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.8 | 5.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.8 | 3.8 | GO:0015871 | choline transport(GO:0015871) |
| 0.7 | 1.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.7 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.7 | 11.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.7 | 10.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.7 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 | 2.9 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.7 | 2.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.7 | 4.3 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.7 | 2.9 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.7 | 2.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
| 0.7 | 2.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.7 | 4.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.7 | 2.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.7 | 2.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.7 | 15.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.7 | 1.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.7 | 3.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.7 | 3.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.7 | 1.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.7 | 2.0 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.7 | 4.8 | GO:0015862 | uridine transport(GO:0015862) |
| 0.7 | 4.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.7 | 1.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.7 | 4.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.7 | 2.0 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.7 | 2.0 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.7 | 6.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.7 | 4.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.7 | 3.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.6 | 0.6 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.6 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.6 | 1.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 | 1.3 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.6 | 3.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.6 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.6 | 5.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.6 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 | 3.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 | 3.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
| 0.6 | 1.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.6 | 6.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.6 | 4.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.6 | 4.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 | 2.4 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.6 | 3.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.6 | 5.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.6 | 3.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.6 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 | 1.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.6 | 7.6 | GO:1901898 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.6 | 1.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.6 | 4.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.6 | 1.7 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.6 | 2.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.6 | 1.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.6 | 1.7 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.6 | 4.5 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.6 | 1.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.6 | 18.9 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
| 0.5 | 1.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 | 3.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.5 | 8.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.5 | 0.5 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.5 | 1.6 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.5 | 2.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.5 | 5.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.5 | 3.7 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.5 | 3.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
| 0.5 | 2.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 1.6 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 | 3.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.5 | 4.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.5 | 5.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.5 | 3.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 30.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.5 | 4.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 | 4.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.5 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.5 | 3.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 | 2.0 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.5 | 2.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.5 | 11.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.5 | 1.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.5 | 1.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.5 | 1.9 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.5 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.5 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.5 | 1.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 | 1.4 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.5 | 2.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.5 | 0.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.5 | 0.5 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.5 | 0.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 2.7 | GO:0002524 | hypersensitivity(GO:0002524) |
| 0.5 | 9.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.5 | 0.5 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.5 | 8.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.4 | 0.4 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.4 | 1.8 | GO:0072185 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.4 | 0.4 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 | 1.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.4 | 0.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 17.2 | GO:0048536 | spleen development(GO:0048536) |
| 0.4 | 0.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.4 | 2.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 | 6.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.4 | 4.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.4 | 2.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.4 | 1.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.4 | 3.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.4 | 2.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.4 | 3.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.4 | 1.7 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.4 | 1.6 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.4 | 25.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.4 | 2.8 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.4 | 2.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.4 | 2.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 | 1.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.4 | 1.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.4 | 16.2 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.4 | 2.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.4 | 18.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.4 | 6.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.4 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 | 8.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.4 | 1.6 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 | 1.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.4 | 2.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 | 6.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 | 1.5 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 5.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.4 | 0.4 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.4 | 1.5 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.4 | 3.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 | 3.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 5.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.4 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.4 | 4.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.4 | 1.5 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.4 | 1.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.4 | 2.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.4 | 1.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.4 | 1.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 | 2.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.4 | 5.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 1.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 10.9 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.4 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.4 | 3.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.4 | 14.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.4 | 1.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.4 | 9.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.4 | 1.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.4 | 1.1 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) single-organism membrane invagination(GO:1902534) |
| 0.4 | 2.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.3 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 3.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 1.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 3.8 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 1.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 | 2.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.3 | 1.7 | GO:0043084 | penile erection(GO:0043084) |
| 0.3 | 1.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 | 1.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 | 3.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 2.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.3 | 2.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 | 2.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.3 | 1.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 2.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.3 | 1.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 2.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 | 5.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 1.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 | 13.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.3 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
| 0.3 | 11.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.3 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 | 1.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 | 13.0 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.3 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 | 1.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.3 | 0.6 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) |
| 0.3 | 3.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 | 1.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 2.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.3 | 3.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 | 2.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.3 | 1.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.3 | 2.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 1.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.3 | 0.3 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.3 | 3.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 3.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 5.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 7.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 | 0.6 | GO:0050908 | detection of visible light(GO:0009584) detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.3 | 2.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.3 | 0.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 | 2.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 | 0.8 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 | 2.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) ferrous iron transmembrane transport(GO:1903874) |
| 0.3 | 5.7 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.3 | 0.3 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.3 | 0.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
| 0.3 | 4.0 | GO:0044091 | membrane biogenesis(GO:0044091) |
| 0.3 | 4.5 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.3 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.3 | 1.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.3 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.3 | 3.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.3 | 0.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 2.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.3 | 3.3 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.2 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 1.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.2 | 9.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.2 | 2.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 | 0.7 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.2 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 0.7 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 | 2.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 4.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.2 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.2 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 2.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 | 0.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.2 | 0.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.2 | 1.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 1.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 | 3.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 3.4 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 0.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.2 | 4.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.2 | 0.9 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.2 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 3.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 | 0.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.2 | 8.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 3.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.2 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 | 1.5 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.2 | 5.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 | 2.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 2.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.2 | 1.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 0.4 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.2 | 1.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 3.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.2 | 0.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 2.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.2 | 0.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.2 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 14.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.2 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 3.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 | 1.3 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.2 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 | 2.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 1.1 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.2 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 | 4.8 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.2 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 | 7.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.2 | 0.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.2 | 4.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 1.0 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
| 0.2 | 1.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 0.2 | 14.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
| 0.2 | 2.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.2 | 4.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 0.2 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) regulation of germinal center formation(GO:0002634) positive regulation of germinal center formation(GO:0002636) |
| 0.2 | 1.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.2 | 0.8 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.2 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.2 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.2 | 2.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 | 1.8 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.2 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 | 3.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.2 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.7 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 2.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 0.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 1.8 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.1 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 2.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 4.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 | 2.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.7 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 | 1.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 2.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 6.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.3 | GO:2000016 | regulation of determination of dorsal identity(GO:2000015) negative regulation of determination of dorsal identity(GO:2000016) |
| 0.1 | 0.5 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 | 0.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 1.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 5.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 | 4.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 2.4 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 1.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
| 0.1 | 3.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 0.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.2 | GO:0002842 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 2.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.1 | 1.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 1.0 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
| 0.1 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 5.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 2.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 1.0 | GO:0006497 | protein lipidation(GO:0006497) |
| 0.1 | 0.4 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 | 0.2 | GO:0097026 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) dendritic cell dendrite assembly(GO:0097026) |
| 0.1 | 2.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 2.5 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 | 1.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.1 | 0.5 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.1 | 0.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 5.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 4.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
| 0.1 | 1.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 | 1.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.8 | GO:0007254 | JNK cascade(GO:0007254) |
| 0.1 | 0.7 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 | 0.2 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.1 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.1 | 1.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 1.6 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 1.7 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
| 0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.4 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.1 | 2.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.1 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.1 | 1.8 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.1 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 0.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 1.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 | 8.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 1.7 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
| 0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 4.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
| 0.1 | 2.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 1.8 | GO:0032872 | regulation of stress-activated MAPK cascade(GO:0032872) |
| 0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 | 1.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.4 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.1 | 1.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 1.0 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.0 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 | 0.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.0 | 0.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.0 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.0 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 1.9 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.0 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 9.5 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
| 0.0 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.9 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.2 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 | 0.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 | 1.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.0 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.9 | GO:0030010 | establishment of cell polarity(GO:0030010) |
| 0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
| 0.0 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.8 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.0 | 0.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
| 0.0 | 0.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.2 | GO:0015844 | monoamine transport(GO:0015844) |
| 0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.3 | 31.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 6.0 | 36.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 4.5 | 22.5 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 3.9 | 19.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.9 | 7.9 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 3.5 | 13.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 3.1 | 9.2 | GO:0098855 | HCN channel complex(GO:0098855) |
| 3.0 | 9.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 2.8 | 75.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 2.7 | 8.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 2.6 | 10.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 2.6 | 31.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.5 | 22.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 2.4 | 9.5 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 2.3 | 35.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 2.1 | 18.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 2.1 | 72.4 | GO:0030673 | axolemma(GO:0030673) |
| 2.0 | 6.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 2.0 | 8.0 | GO:0031673 | H zone(GO:0031673) |
| 2.0 | 2.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 1.9 | 24.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.8 | 5.3 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.6 | 13.0 | GO:0005883 | neurofilament(GO:0005883) |
| 1.6 | 3.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.6 | 14.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 1.6 | 4.7 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.5 | 12.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 1.5 | 4.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.4 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.4 | 4.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.3 | 50.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 1.3 | 6.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.3 | 11.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.3 | 3.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 1.2 | 4.7 | GO:0008091 | spectrin(GO:0008091) |
| 1.1 | 16.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.1 | 4.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 1.0 | 10.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 1.0 | 18.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 8.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.9 | 2.7 | GO:0044304 | main axon(GO:0044304) |
| 0.9 | 4.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.9 | 3.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.9 | 3.5 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.8 | 39.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.8 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.8 | 2.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.8 | 68.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.8 | 9.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.7 | 8.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.7 | 5.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.7 | 6.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.7 | 6.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.7 | 19.4 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.7 | 4.0 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.7 | 1.3 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.7 | 2.7 | GO:0090537 | CERF complex(GO:0090537) |
| 0.7 | 3.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.7 | 2.0 | GO:0005940 | septin ring(GO:0005940) |
| 0.7 | 8.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.6 | 24.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.6 | 1.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.6 | 1.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.6 | 4.3 | GO:0070695 | FHF complex(GO:0070695) |
| 0.6 | 129.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.6 | 5.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.6 | 4.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.6 | 1.7 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.6 | 1.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.5 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 4.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.5 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.5 | 3.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.5 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.5 | 2.5 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.5 | 6.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.5 | 3.4 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.5 | 4.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 6.2 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.5 | 4.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.5 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.5 | 8.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.5 | 86.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.5 | 12.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.5 | 6.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.5 | 6.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.4 | 4.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.4 | 3.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.4 | 1.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.4 | 2.9 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.4 | 5.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.4 | 9.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.4 | 3.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 3.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.4 | 8.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.4 | 3.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.4 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.4 | 1.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.4 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
| 0.3 | 12.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.3 | 1.0 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.3 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 2.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 11.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 3.9 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 5.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 3.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.3 | 10.1 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.3 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 14.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 1.2 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 0.3 | 5.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.3 | 12.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.3 | 12.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.3 | 1.4 | GO:1903440 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.3 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 2.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 1.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 7.6 | GO:0005938 | cell cortex(GO:0005938) |
| 0.3 | 2.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.3 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 28.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.3 | 21.6 | GO:0043204 | perikaryon(GO:0043204) |
| 0.3 | 0.8 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
| 0.3 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 7.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.3 | 1.3 | GO:0005605 | basal lamina(GO:0005605) |
| 0.3 | 4.4 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.3 | 5.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 0.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.2 | 5.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 1.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 8.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.2 | 1.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 3.5 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 7.3 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 5.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 7.4 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 3.3 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 0.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 6.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.2 | 5.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 1.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.2 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 8.3 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.2 | 11.4 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 9.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 2.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 5.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.2 | 12.0 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 2.2 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.1 | 1.1 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) myosin filament(GO:0032982) |
| 0.1 | 12.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.3 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.1 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 4.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.3 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 10.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 1.5 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 1.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 3.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.7 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 9.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 1.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 42.1 | GO:0005768 | endosome(GO:0005768) |
| 0.1 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 2.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 7.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.1 | 2.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
| 0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 2.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 12.7 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 190.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 1.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 12.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.1 | 1.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 2.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.0 | 0.4 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 1.4 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 3.6 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 1.5 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 1.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 2.2 | GO:0005773 | vacuole(GO:0005773) |
| 0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.2 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.6 | 34.7 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 7.6 | 37.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 6.6 | 26.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 5.0 | 14.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 4.0 | 28.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 3.9 | 11.7 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 3.7 | 33.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 3.3 | 26.3 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 3.3 | 19.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 3.1 | 18.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 3.0 | 9.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 3.0 | 12.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 3.0 | 12.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 3.0 | 8.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 2.8 | 16.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 2.7 | 8.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 2.7 | 11.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 2.7 | 10.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 2.6 | 7.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 2.5 | 7.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 2.4 | 2.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 2.4 | 11.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 2.3 | 9.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 2.2 | 19.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 2.1 | 6.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 2.1 | 12.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 2.1 | 14.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 2.0 | 6.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 2.0 | 9.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.9 | 11.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.8 | 16.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.8 | 1.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.8 | 9.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 1.8 | 10.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 1.8 | 9.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.7 | 13.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.7 | 20.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 1.7 | 10.3 | GO:0097001 | ceramide binding(GO:0097001) |
| 1.7 | 5.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.6 | 6.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.6 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 1.6 | 8.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.6 | 4.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 1.5 | 6.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.4 | 11.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 1.4 | 5.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.4 | 4.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 1.4 | 5.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 1.4 | 5.4 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 1.4 | 9.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.3 | 8.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.3 | 56.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 1.3 | 8.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 1.3 | 11.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 1.2 | 8.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) heterotrimeric G-protein binding(GO:0032795) |
| 1.2 | 10.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 1.2 | 4.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.2 | 3.5 | GO:0070905 | serine binding(GO:0070905) |
| 1.1 | 6.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.1 | 4.3 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.1 | 4.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.0 | 4.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 1.0 | 7.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 1.0 | 18.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 1.0 | 14.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 1.0 | 1.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 1.0 | 4.0 | GO:0004096 | catalase activity(GO:0004096) |
| 1.0 | 7.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.0 | 6.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 1.0 | 8.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 1.0 | 5.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.0 | 1.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.0 | 4.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 1.0 | 7.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.0 | 6.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.0 | 3.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.9 | 15.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.9 | 26.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.9 | 18.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.9 | 4.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.9 | 13.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.9 | 6.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.9 | 4.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.9 | 2.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.9 | 7.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.9 | 13.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.9 | 2.7 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 0.9 | 11.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.9 | 4.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.9 | 3.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.9 | 10.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.8 | 7.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.8 | 32.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.8 | 9.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.8 | 10.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.8 | 2.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.8 | 2.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.8 | 4.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.8 | 3.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.8 | 5.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.8 | 6.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.7 | 11.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.7 | 8.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.7 | 2.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.7 | 2.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.7 | 7.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.7 | 5.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.7 | 4.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.7 | 1.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.7 | 19.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.7 | 2.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.7 | 8.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.7 | 6.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.7 | 6.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.7 | 3.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.6 | 2.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.6 | 3.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.6 | 4.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.6 | 13.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.6 | 19.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.6 | 11.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.6 | 1.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.6 | 5.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.6 | 2.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
| 0.6 | 1.8 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.6 | 3.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.6 | 2.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.6 | 2.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.6 | 13.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.6 | 2.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.5 | 2.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.5 | 2.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.5 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.5 | 2.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.5 | 8.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.5 | 18.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.5 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.5 | 1.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 2.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.5 | 1.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.5 | 2.4 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 79.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.5 | 4.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.5 | 2.3 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.5 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.5 | 0.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.5 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.5 | 2.3 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 3.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 0.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.4 | 0.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.4 | 6.6 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.4 | 7.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 1.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.4 | 7.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.4 | 1.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.4 | 13.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.4 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
| 0.4 | 2.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 1.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.4 | 4.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.4 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.4 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.4 | 16.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.4 | 7.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.4 | 1.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 3.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.4 | 1.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.4 | 13.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.4 | 4.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.4 | 19.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.4 | 4.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 1.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.4 | 5.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.4 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 1.1 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.3 | 1.4 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
| 0.3 | 1.0 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.3 | 1.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.3 | 1.0 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.3 | 1.0 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 5.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 1.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 1.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.3 | 2.7 | GO:0036122 | BMP binding(GO:0036122) |
| 0.3 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 5.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 6.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 1.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.3 | 17.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.3 | 6.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 5.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 1.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 2.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.3 | 2.2 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.3 | 3.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.3 | 3.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.3 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.3 | 9.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 3.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 0.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) |
| 0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 4.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.3 | 6.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.3 | 1.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.3 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 3.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.3 | 2.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 6.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.3 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 6.9 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.3 | 3.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 2.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.3 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 6.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.3 | 1.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.3 | 3.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 24.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.3 | 1.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 19.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.3 | 2.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.2 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.2 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 12.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 0.7 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.2 | 1.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.2 | 0.7 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.2 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 4.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 0.7 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.2 | 0.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.2 | 4.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 4.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.2 | 4.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 4.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.2 | 16.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 1.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.2 | 1.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.2 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 1.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 4.9 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.2 | 101.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.2 | 3.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 9.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 9.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 36.0 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.2 | 2.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.2 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.2 | 4.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 6.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 7.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.2 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.2 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 0.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 1.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 1.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.2 | 0.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.2 | 8.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 1.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 2.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 0.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 2.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 4.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.1 | 1.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 6.1 | GO:0001653 | peptide receptor activity(GO:0001653) |
| 0.1 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.1 | 5.6 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 1.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.1 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 5.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.4 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 3.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.4 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 14.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 9.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.1 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.1 | 0.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 1.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.6 | GO:0002135 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
| 0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 0.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.6 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.1 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 2.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.1 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 4.9 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 3.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 12.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.1 | 0.2 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.1 | 2.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 3.1 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.7 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.1 | 1.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 14.4 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 1.9 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 2.0 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 6.6 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.0 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 3.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 4.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.0 | 1.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 2.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.0 | 3.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 1.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 1.3 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 2.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 1.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.0 | 0.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
| 0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 41.3 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 1.1 | 3.4 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.9 | 16.1 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.9 | 39.9 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.9 | 26.7 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.9 | 26.6 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 1.6 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.7 | 24.2 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.7 | 9.6 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.7 | 35.8 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.6 | 24.1 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.6 | 12.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.6 | 22.2 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.6 | 10.9 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.6 | 16.1 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.5 | 3.2 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.5 | 16.9 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.5 | 16.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.5 | 2.0 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.5 | 1.0 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.5 | 37.0 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.4 | 4.0 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.4 | 16.0 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.4 | 11.4 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 3.9 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 15.1 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.4 | 6.4 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.4 | 7.1 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.4 | 5.0 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.4 | 0.4 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.4 | 25.5 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.4 | 25.6 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.3 | 0.7 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 2.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 4.2 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.3 | 1.2 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.3 | 1.1 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.3 | 7.1 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.3 | 2.8 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.2 | 1.4 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 5.2 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.2 | 3.0 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 5.4 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.2 | 1.5 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.2 | 2.5 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.2 | 9.5 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.2 | 3.1 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.2 | 3.1 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.2 | 2.7 | PID_ARF6_PATHWAY | Arf6 signaling events |
| 0.2 | 1.0 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.2 | 3.5 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 1.4 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 1.7 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 4.5 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.1 | 1.3 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.4 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.9 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.6 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 0.6 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.1 | 1.1 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.1 | 1.8 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.2 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.2 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 0.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.7 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 0.3 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 2.5 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 0.6 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.5 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 0.8 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.6 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.9 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.5 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.0 | 0.5 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.4 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.4 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.3 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.0 | 0.3 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.3 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.3 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.3 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.0 | 1.8 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.1 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 27.9 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 2.8 | 44.2 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 2.4 | 30.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 2.2 | 51.8 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 2.1 | 6.4 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 1.3 | 17.5 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 1.2 | 12.3 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 1.2 | 9.8 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 1.2 | 12.0 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 1.1 | 7.8 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 1.1 | 14.1 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.9 | 37.7 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.8 | 10.2 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.8 | 15.5 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.8 | 2.3 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.7 | 9.1 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.7 | 8.7 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.6 | 1.3 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.6 | 5.7 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.6 | 14.5 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.6 | 11.4 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.6 | 8.3 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.6 | 6.8 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.6 | 11.1 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.5 | 5.5 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.5 | 16.9 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.5 | 11.9 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 2.1 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.5 | 11.8 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.5 | 7.2 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.5 | 15.6 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.5 | 10.2 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 8.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.4 | 7.0 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.4 | 5.3 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.4 | 13.3 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.4 | 10.3 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 8.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.4 | 3.5 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 8.7 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 2.6 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 2.6 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.4 | 6.1 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.4 | 1.4 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 12.7 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.4 | 12.4 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.3 | 0.7 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.3 | 24.1 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 2.7 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 7.0 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.3 | 18.1 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.3 | 2.8 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.3 | 3.9 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 2.7 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 1.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.3 | 5.9 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.3 | 6.2 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.3 | 8.6 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.3 | 10.5 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 1.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 10.5 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.2 | 0.5 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.2 | 5.4 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 2.0 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 0.9 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.2 | 7.4 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 4.8 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.2 | 3.1 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 3.5 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 6.2 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 5.1 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 4.5 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 2.4 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.2 | 5.1 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 0.5 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.2 | 1.0 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 2.4 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 5.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 3.6 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 5.6 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.2 | 1.7 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 1.7 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 1.9 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 0.9 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.1 | 3.8 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.8 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.1 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 0.5 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 4.4 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 2.2 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 2.7 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 1.9 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.6 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.1 | 0.2 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 6.3 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 0.6 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 2.9 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 1.4 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.8 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.1 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 4.0 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.1 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.8 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 1.2 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.3 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.8 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 2.8 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.5 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 0.7 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 0.7 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 4.4 | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 1.0 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 2.1 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.0 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 2.7 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.8 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.1 | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 0.0 | 1.0 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.2 | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.1 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
|
|
|